Related Experiment Videos
Bacterial meningitis in the newborn: a prospective study of mortality and morbidity
D Harvey1, D E Holt, H Bedford
1Karim Centre for Meningitis Research, ICSM Department of Paediatrics and Neonatal Medicine, Queen Charlotte's and Chelsea Hospital, London, England.
Abstract:
Neonatal bacterial meningitis is a serious disease around the world, with the incidence changing little in the past 30 years. Group B streptococci, Escherichia coli, and Klebsiella pneumoniae are common causative organisms and lumbar puncture remains the definitive method of diagnosis. The mortality rate has declined in industrialized countries over the years, from almost 50% in the 1970s to less than 10% in 1997. However, neurological sequelae are still frequently observed despite major changes in treatment. Preliminary analysis of our own data from a prospective study of cases in the United Kingdom suggests that treatment with third generation cephalosporins is related to a decrease in mortality but not morbidity.
Insights
Neonatal bacterial meningitis remains a global concern. While third-generation cephalosporins may reduce mortality, they do not appear to decrease neurological complications in newborns.
Area of Science:
- Neonatal infectious diseases
- Bacterial meningitis
- Pediatric neurology
Background:
- Neonatal bacterial meningitis is a significant worldwide health issue with persistent incidence.
- Common pathogens include Group B Streptococcus, Escherichia coli, and Klebsiella pneumoniae.
- Lumbar puncture is the gold standard for diagnosis.
Purpose of the Study:
- To analyze the impact of third-generation cephalosporins on neonatal bacterial meningitis outcomes.
- To investigate the relationship between antibiotic treatment and mortality and morbidity.
Main Methods:
- Prospective study design.
- Analysis of clinical data from neonatal bacterial meningitis cases in the United Kingdom.
- Evaluation of treatment regimens, specifically third-generation cephalosporins.
Main Results:
- Mortality rates for neonatal bacterial meningitis have declined significantly in industrialized nations.
- Preliminary data suggest third-generation cephalosporins are associated with reduced mortality.
- No significant decrease in neurological sequelae (morbidity) was observed with this treatment.
Conclusions:
- Third-generation cephalosporins may improve survival rates in neonatal bacterial meningitis.
- Further research is needed to address the persistent issue of neurological morbidity despite advances in treatment.
- Optimizing treatment strategies to reduce long-term neurological deficits is crucial.